BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Solvay SA 

Rue du Prince Albert 33

Brussels    B-1050  Belgium
Phone: 32-0-2-509-661 Fax: 32-0-2-509-6624


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
CordenPharma to Acquire Peptisyntha From Solvay SA, Expanding Peptides Custom Synthesis Business 8/28/2013 10:36:26 AM    More...
Solvay SA: Operating result from the Chemicals and Plastics activities for the third quarter of 2010 (EUR 149 million) significantly higher (+60% at constant scope 1 ) compared to the third quarter of 2009 10/28/2010 9:44:36 AM    More...
Solvay SA to Cut 800 Jobs, Eyes 120 Mln Euro Savings 9/23/2010 6:48:12 AM    More...
Abbott Laboratories (ABT) Puts Former Solvay SA Flu-Vaccine Business Up for Sale; Could be Worth $619 Million 6/29/2010 6:59:19 AM    More...
Solvay SA : Operating Result In The Fourth Quarter (EUR 313 Million) Clearly Improved Compared To Last Year (EUR 125 Million) In Every Sector Of Activity; For The Year Overall, The Decrease Was Limited To 6% 2/18/2010 11:39:44 AM    More...
Clariant Named as Possible Solvay SA Target 9/30/2009 8:25:04 AM    More...
MediGene AG (DX:MDG) Signs Agreement with Solvay SA for the Commercialization of Veregen(R) in Germany, Austria, and Switzerland 9/29/2009 3:04:11 PM    More...
Solvay SA : Good Resilience In Second Quarter Operating Result (EUR 164 Million), Up From The First Quarter (EUR 142 Million) 7/30/2009 10:55:38 AM    More...
Solvay SA to Get Bids for Drug Unit Friday Say Sources 5/28/2009 7:17:47 AM    More...
Solvay SA's 1st Quarter 2009 Results 5/12/2009 11:40:25 AM    More...
1234